Interestingly, aurothiomalate (ATM)—the same chemical class molecule as auranofin—was demonstrated to disrupt the binding of PKCζ to Par-6 in pancreatic cancer cells (Butler et al., 2015). This evidence concerns the gene PARD6A and pancreatic neoplasm.